Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Bladder01:23

Urinary Bladder

4.6K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
4.6K
The Micturition Reflex01:26

The Micturition Reflex

3.8K
Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
3.8K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

950
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
950
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

360
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
360
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

627
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
627
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

412
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
412

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing European cities with the 3-30-300 rule underscores the need for enhanced urban greening efforts.

Nature communications·2026
Same author

Caribbean fish feces are an environmental hotspot of viable Symbiodiniaceae.

Frontiers in microbiology·2026
Same author

[Artificial intelligence in surgical disciplines: Clinical application, advantages, and potential-a Delphi expert consensus].

Urologie (Heidelberg, Germany)·2026
Same author

Genome Skimming Illuminates Hidden Species Diversity and Symbiodiniaceae Associations in East Pacific Pocillopora Corals.

Genome biology and evolution·2025
Same author

Characterizing α-phase variants in titanium alloys via EBSD: Understanding colour indexing challenges.

Micron (Oxford, England : 1993)·2025
Same author

[Digital urology : Possible uses for artificial intelligence and digital health applications].

Urologie (Heidelberg, Germany)·2025
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.4K

[Therapy of overactive bladder (OAB)].

M Kurosch1, R Mager, K Gust

  • 1Klinik für Urologie und Kinderurologie, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland, Martin.Kurosch@kgu.de.

Der Urologe. Ausg. A
|March 12, 2015
PubMed
Summary
This summary is machine-generated.

Overactive bladder (OAB) affects 17% of Europeans, causing stress and healthcare costs. Recent research offers new treatments, including medications and surgical options, to manage OAB symptoms effectively.

More Related Videos

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

18.5K
Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
10:19

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

20.0K

Related Experiment Videos

Last Updated: Apr 16, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.4K
Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

18.5K
Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
10:19

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

20.0K

Area of Science:

  • Urology
  • Pharmacology
  • Pathophysiology

Context:

  • Overactive bladder (OAB) is a prevalent condition affecting 17% of the European population.
  • OAB presents with or without incontinence, significantly impacting patients' psychological well-being and incurring substantial healthcare costs.
  • Etiology involves complex myogenic, urothelial, and neurogenic factors leading to tissue changes.

Purpose:

  • To review recent advancements in understanding and treating overactive bladder.
  • To highlight new therapeutic agents and approaches for OAB management.
  • To emphasize the continued importance of non-pharmaceutical and surgical interventions.

Summary:

  • Recent research has improved pathophysiological models for OAB.
  • New pharmacological agents are increasingly utilized alongside traditional therapies for OAB.
  • Non-pharmaceutical interventions and surgical techniques remain crucial components of OAB treatment.

Impact:

  • Improved understanding of OAB pathophysiology.
  • Expanded therapeutic options for OAB patients.
  • Potential for reduced patient distress and healthcare expenditure associated with OAB.